About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Crinecerfont (Crinecerfont)

[1] Crinecerfont (Crinecerfont) 💬

[1] CRHR1 💬

[5] Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 81 💬

2

Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.

[2] Corticotropin,
Crinecerfont (Crinecerfont)

[3] Corticotropin ,
Corticotropin, repository ,
Crinecerfont (Crinecerfont) 💬

[2] CRHR1,
MC2R 💬

[7] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 81 💬

3

CrinecerfontProduct Code: NBI-74788 Pharmaceutical Form: Capsule, hardINN or Proposed INN: CrinecerfontCAS Number: 752253-39-7Current Sponsor code: NBI-74788Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use

-

-

-

-

[1] 81 💬